Replimune Group Stock Market Value
| REPL Stock | USD 7.90 0.79 11.11% |
| Symbol | Replimune |
Replimune Group Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.24) | Return On Assets (0.26) | Return On Equity (0.46) |
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Replimune 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Replimune's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Replimune.
| 05/10/2024 |
| 06/09/2024 |
If you would invest 0.00 in Replimune on May 10, 2024 and sell it all today you would earn a total of 0.00 from holding Replimune Group or generate 0.0% return on investment in Replimune over 30 days. Replimune is related to or competes with Crispr Therapeutics, Ocean Biomedical, Enveric Biosciences, Hepion Pharmaceuticals, Elevation Oncology, AVROBIO, and PTC Therapeutics. Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer More
Replimune Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Replimune's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Replimune Group upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 15.06 | |||
| Value At Risk | (7.46) | |||
| Potential Upside | 7.28 |
Replimune Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Replimune's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Replimune's standard deviation. In reality, there are many statistical measures that can use Replimune historical prices to predict the future Replimune's volatility.| Risk Adjusted Performance | 4.0E-4 | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | (0.15) | |||
| Treynor Ratio | (0.05) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Replimune's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Replimune Group Backtested Returns
Replimune Group maintains Sharpe Ratio (i.e., Efficiency) of -0.0087, which implies the firm had a -0.0087% return per unit of risk over the last 3 months. Replimune Group exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Replimune's Risk Adjusted Performance of 4.0E-4, variance of 27.79, and Coefficient Of Variation of (7,390) to confirm the risk estimate we provide. The company holds a Beta of 1.57, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Replimune will likely underperform. At this point, Replimune Group has a negative expected return of -0.0465%. Please make sure to check Replimune's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Replimune Group performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.82 |
Excellent reverse predictability
Replimune Group has excellent reverse predictability. Overlapping area represents the amount of predictability between Replimune time series from 10th of May 2024 to 25th of May 2024 and 25th of May 2024 to 9th of June 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Replimune Group price movement. The serial correlation of -0.82 indicates that around 82.0% of current Replimune price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.82 | |
| Spearman Rank Test | -0.43 | |
| Residual Average | 0.0 | |
| Price Variance | 1.28 |
Replimune Group lagged returns against current returns
Autocorrelation, which is Replimune stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Replimune's stock expected returns. We can calculate the autocorrelation of Replimune returns to help us make a trade decision. For example, suppose you find that Replimune has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Replimune regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Replimune stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Replimune stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Replimune stock over time.
Current vs Lagged Prices |
| Timeline |
Replimune Lagged Returns
When evaluating Replimune's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Replimune stock have on its future price. Replimune autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Replimune autocorrelation shows the relationship between Replimune stock current value and its past values and can show if there is a momentum factor associated with investing in Replimune Group.
Regressed Prices |
| Timeline |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Replimune Group using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in Replimune Stock
When determining whether Replimune Group is a strong investment it is important to analyze Replimune's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Replimune's future performance. For an informed investment choice regarding Replimune Stock, refer to the following important reports:Check out Replimune Correlation, Replimune Volatility and Replimune Alpha and Beta module to complement your research on Replimune. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Replimune technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.